The incidence of factor VIII inhibitors in the United Kingdom, 1990‐93
- 1 April 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 89 (4) , 908-910
- https://doi.org/10.1111/j.1365-2141.1995.tb08435.x
Abstract
Reports of all the factor VIII inhibitors arising in the United Kingdom in patients with haemophilia A during the years 1990-93 have been collated by the United Kingdom Haemophilia Centre Directors Organization. 32 new inhibitors were reported during this period, giving an average incidence of new inhibitors of 1.5 per 1000 patients registered per year. Although most occurred in patients with severe haemophilia under the age of 10, 29% occurred in patients whose VIIIC was > 3 iu/dl, and 38% in patients over the age of 10 years. The incidence of inhibitors rose during the study period, but this change was not statistically significant.Keywords
This publication has 10 references indexed in Scilit:
- Acquired factor VIII inhibitor associated with chronic interferon‐alpha therapy in a patient with haemophilia ABritish Journal of Haematology, 1994
- Clinical Course of Factor VIII Inhibitors Developed after Exposure to a Pasteurised Dutch Concentrate Compared to Classic Inhibitors in Hemophilia AThrombosis and Haemostasis, 1994
- Factor VIII inhibitorsThe Lancet, 1993
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993
- A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study GroupBlood, 1993
- Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of InhibitorsNew England Journal of Medicine, 1993
- A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII ConcentrateThrombosis and Haemostasis, 1993
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Factor VIII:C inhibitor associated with monoclonal-antibody purified FVIII concentrateThe Lancet, 1990
- The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitorsBlood, 1988